Provided by Tiger Trade Technology Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.9545
+0.05225.79%
Post-market: 0.97820.0237+2.48%19:58 EDT
Volume:852.12K
Turnover:807.21K
Market Cap:121.30M
PE:-2.14
High:0.9782
Open:0.9200
Low:0.8900
Close:0.9023
52wk High:4.31
52wk Low:0.6200
Shares:127.08M
Float Shares:63.02M
Volume Ratio:1.63
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4464
EPS(LYR):-0.4673
ROE:-36.21%
ROA:-20.83%
PB:0.93
PE(LYR):-2.04

Loading ...

Nautilus Biotechnology to report first-quarter results, host conference call

Reuters
·
Apr 09

Nautilus Biotechnology to Present at Investor Summit Group Virtual Conference

Reuters
·
Mar 24

Nautilus names Baylor College of Medicine as first Voyager platform Early Access customer

Reuters
·
Mar 18

Nautilus Biotechnology CEO Sujal M Patel Acquires Common Shares

Reuters
·
Mar 05

Press Release: Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

Dow Jones
·
Mar 02

Nautilus Biotechnology Is Maintained at Buy by Guggenheim

Dow Jones
·
Feb 27

Nautilus Q4 operating expenses fall 23%, net loss narrows

Reuters
·
Feb 26

BRIEF-Nautilus Biotechnology Q4 EPS USD -0.11

Reuters
·
Feb 26

Nautilus Biotechnology Q4 Operating Expenses USD 15.424 Million

THOMSON REUTERS
·
Feb 26

Nautilus Biotechnology Q4 Net Income USD -13.781 Million

THOMSON REUTERS
·
Feb 26

Press Release: Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Dow Jones
·
Feb 26

Nautilus Biotechnology Inc: in 2026, We Do Not Anticipate Material Revenue From Early Access Program Engagements

THOMSON REUTERS
·
Feb 26

Nautilus Biotechnology Inc - in 2026, Expect Operating Expenses to Increase by About 15–20% YoY Compared to 2025 - SEC Filing

THOMSON REUTERS
·
Feb 26

Nautilus Biotechnology Inc - Q4 Net Loss per Share $0.11 - SEC Filing

THOMSON REUTERS
·
Feb 26

Nautilus Biotechnology Q4 EPS $(0.11) Beats $(0.14) Estimate

Benzinga Earnings
·
Feb 26

Nautilus Biotechnology Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
Feb 24

BRIEF-Nautilus Biotechnology Inc - Commercial Launch Of Voyager Platform Expected In Late 2026

Reuters
·
Feb 24

Nautilus Biotechnology Inc - Commercial Launch of Voyager Platform Expected in Late 2026

THOMSON REUTERS
·
Feb 24

Nautilus Biotechnology Unveils Voyager Platform at US HUPO 2026

Reuters
·
Feb 24

Nautilus Biotechnology to Join TD Cowen 46th Annual Health Care Conference Fireside Chat

Reuters
·
Feb 20